期刊文献+

川崎病的诊治探讨

To Investigate the Diagnosis and Treatment of Kawasaki Disease
下载PDF
导出
摘要 目的回顾性分析25例川崎病的诊疗过程,研究川崎病的一般病理特点以及临床上有效的治疗方式。方法选取我院2008年1月~2011年10月收治的25例川崎病患者作为研究对象,分析所有患者的临床表现特点,并对所有患者的临床治疗效果进行总结分析。结果川崎病患儿常表现有冠状动脉扩张或管壁增厚毛糙、血WBC、肝功能损害及心肌酶升高等现象。结论临床医学上认为EB病毒感染以及支原体感染都和川崎病具有一定的联系,并且实验中显示单剂大量丙种球蛋白对该疾病的临床疗效较好。 Objective A retrospective analysis of 25 cases of the treatment process Kawasaki disease,treatment of disease Kawasaki general pathological features and clinical effective.Methods 25 cases of Kawasaki disease patients as the research object in our hospital from 2008 January to 2011 October,analysis the clinical features of all patients,and the clinical outcomes of all patients were analyzed.Results Children with Kawasaki disease often showed dilatation of coronary artery wall thickening or rough,liver function damage and myocardial enzyme WBC,blood rising phenomenon.Conclusion Clinical medicine that EB virus infection and mycoplasma infection and Kawasaki disease had a certain relationship,and the experiment shows better clinical effect of single dose of a large number of gamma globulin for this disease,and can be used in clinical practice.
作者 郭振
出处 《中国继续医学教育》 2015年第17期54-55,共2页 China Continuing Medical Education
关键词 川崎病 丙种球蛋白 冠状动脉 临床疗效 Kawasaki disease Immunoglobulin Coronary artery Clinical curative effect
  • 相关文献

参考文献5

二级参考文献17

  • 1温静.超声心动图在川崎病冠状动脉病变中的应用[J].医学影像学杂志,2012,22(2):194-195. 被引量:7
  • 2杜军保.进一步提高川崎病的临床诊疗水平[J].中华儿科杂志,2006,44(5):321-323. 被引量:96
  • 3张伟,李秋,赵晓东,唐雪梅,王晓刚,王墨,吴道奇,欧茜,杨锡强.942例川崎病的临床分析[J].中华儿科杂志,2006,44(5):324-328. 被引量:147
  • 4张清友,杜军保.不完全川崎病的诊治现状[J].中华儿科杂志,2006,44(5):339-341. 被引量:149
  • 5张永兰,袁越.川崎病与A族链球菌[J].临床儿科杂志,2006,24(6):460-461. 被引量:6
  • 6[1]Kitaoka LL, Takata J, Hitomi N, et al. Effect of angiotensin-converting enzyme inhibitor (enalapril or imidapril)on chronic heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol,2000,85(5):658
  • 7[2]Civertz MM, Collucci WS. New targets for heart failure therapy:endothelin, inflammatory, cytokines, oxidative stress. Lancet, 1998,352(suppl 1):34
  • 8[3]Packer M,Cohn JN. On behalf of ACTION-HF:consensus recommendations for the management of chronic heart failure. Am J Cardiol, 1999,83:1
  • 9[4]Masura J,Gavora P, Formanek A, et al. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder:intial human experience. Cathet Cardiovasc Diagn,1997,42:388
  • 10[5]Yanagawa H, Tuohong Z,Oki I, et al. Effects of gamma-globulin on the cardiac sequelae of kawasaki disease. Pediatr Cardiol, 1999,29(4):248

共引文献1984

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部